stockrowAlamar Biosciences, Inc. (ALMR) vs Enovis Corporation (ENOV)
- Alamar Biosciences, Inc. ALMR 27.88 +3.60%
- Enovis Corporation ENOV 27.07 −5.42%
Alamar Biosciences, Inc. and Enovis Corporation are both Medical Devices companies. Alamar Biosciences, Inc. is the larger, with a market value of $1.9B against $1.7B — 1.1× the size. Enovis Corporation has the higher net margin (−22.9% vs −48.2%) and the higher return on invested capital (−10.8% vs −38.9%). Across the 16 metrics below, Enovis Corporation leads on 11 and Alamar Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | ALMR | ENOV | Medical Devices median |
|---|---|---|---|
| Gross margin | 59.32% | 61.31% | 57.76% |
| Operating margin | (42.08%) | (20.59%) | (14.84%) |
| Net margin | (48.23%) | (22.87%) | (14.45%) |
| Free cash flow margin | (60.03%) | 3.02% | (5.70%) |
| Return on equity | (64.60%) | (29.97%) | (10.56%) |
| Return on assets | (20.85%) | (12.91%) | (17.26%) |
| Return on invested capital | (38.90%) | (10.83%) | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack